Bionano Genomics, Inc.
BNGO
$3.57
-$0.08-2.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 84.59% | 54.52% | -172.72% | 48.37% | 28.41% |
| Total Depreciation and Amortization | 1.47% | -56.88% | 86.90% | -0.62% | -16.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -146.82% | -62.98% | 801.05% | 32.27% | -130.31% |
| Change in Net Operating Assets | -10.68% | 89.22% | 127.45% | -182.28% | 184.79% |
| Cash from Operations | 57.50% | 51.13% | 36.56% | 25.43% | 5.53% |
| Capital Expenditure | -- | -- | 100.00% | -196.15% | 96.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -569.34% | 155.76% | -118.72% | -39.70% | 187.16% |
| Cash from Investing | -569.34% | 155.76% | -118.77% | -39.83% | 185.94% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 99.21% | 33.20% | 87.62% | 33.60% | -306.93% |
| Issuance of Common Stock | 98.24% | -33.52% | -16.90% | -21.21% | 36.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -195.72% | 23.98% | 86.20% | -1,919.43% | 97.20% |
| Cash from Financing | 179.97% | -35.39% | 404.40% | 90.85% | -131.57% |
| Foreign Exchange rate Adjustments | -125.00% | -116.67% | 2,500.00% | 96.15% | -154.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,669.39% | 103.00% | -322.75% | 359.21% | 86.83% |